IL154609A0 - Anti-angiogenic polypeptides - Google Patents

Anti-angiogenic polypeptides

Info

Publication number
IL154609A0
IL154609A0 IL15460901A IL15460901A IL154609A0 IL 154609 A0 IL154609 A0 IL 154609A0 IL 15460901 A IL15460901 A IL 15460901A IL 15460901 A IL15460901 A IL 15460901A IL 154609 A0 IL154609 A0 IL 154609A0
Authority
IL
Israel
Prior art keywords
angiogenic polypeptides
angiogenic
polypeptides
Prior art date
Application number
IL15460901A
Original Assignee
Bioacta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0021475A external-priority patent/GB0021475D0/en
Priority claimed from GB0027395A external-priority patent/GB0027395D0/en
Priority claimed from GB0117737A external-priority patent/GB0117737D0/en
Application filed by Bioacta Ltd filed Critical Bioacta Ltd
Publication of IL154609A0 publication Critical patent/IL154609A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15460901A 2000-09-01 2001-09-03 Anti-angiogenic polypeptides IL154609A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0021475A GB0021475D0 (en) 2000-09-01 2000-09-01 Anti-aniogenic peptides
GB0027395A GB0027395D0 (en) 2000-11-09 2000-11-09 Anti-angiogenic peptides
US25289600P 2000-11-27 2000-11-27
GB0117737A GB0117737D0 (en) 2001-07-23 2001-07-23 Modified peptides
PCT/GB2001/003926 WO2002018440A1 (en) 2000-09-01 2001-09-03 Anti-angiogenic peptides

Publications (1)

Publication Number Publication Date
IL154609A0 true IL154609A0 (en) 2003-09-17

Family

ID=27447880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15460901A IL154609A0 (en) 2000-09-01 2001-09-03 Anti-angiogenic polypeptides

Country Status (8)

Country Link
EP (1) EP1315755A1 (en)
JP (1) JP2004512832A (en)
CN (1) CN1592755A (en)
AU (1) AU2001284235A1 (en)
BR (1) BR0113674A (en)
CA (1) CA2420765A1 (en)
IL (1) IL154609A0 (en)
WO (1) WO2002018440A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1478665A2 (en) * 2002-02-19 2004-11-24 Novartis AG Organic compounds having anti-angiogenic activity
GB0217018D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 1
FR2846659B1 (en) * 2002-10-30 2005-02-18 Centre Nat Rech Scient PEPTIDE FRAGMENTS OF THE HARP FACTOR INHIBITING ANGIOGENESIS
US7785601B2 (en) * 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
EP2144927B1 (en) * 2007-04-11 2012-04-04 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
DE602007009797D1 (en) * 2007-04-11 2010-11-25 Gene Signal Int Sa Antitumor remedy, medicament, composition and use thereof
US8372810B2 (en) 2007-04-11 2013-02-12 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
CN107973839B (en) * 2017-12-11 2020-09-04 暨南大学 Active peptide for inhibiting malignant tumor and enhancing curative effect of chemical medicine and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639940A (en) * 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
AU3199999A (en) * 1998-03-24 1999-10-18 Children's Medical Center Corporation Endostatin derived peptides with anti-angiogenic and anti-cancer activity

Also Published As

Publication number Publication date
JP2004512832A (en) 2004-04-30
CA2420765A1 (en) 2002-03-07
AU2001284235A1 (en) 2002-03-13
EP1315755A1 (en) 2003-06-04
BR0113674A (en) 2003-06-03
WO2002018440A1 (en) 2002-03-07
CN1592755A (en) 2005-03-09

Similar Documents

Publication Publication Date Title
DE60104306D1 (en) Neue phenylpropargyletherderivate
IL154609A0 (en) Anti-angiogenic polypeptides
AU6268901A (en) Oligopeptides
EP1359932A4 (en) Tip39 polypeptides
GB0015761D0 (en) Polypeptide
GB0112342D0 (en) Polypeptides
AU2002230895A8 (en) Protein-protein interactions
GB0001825D0 (en) Peptides
AU5496701A (en) Anti-angiogenic polypeptides
GB0018307D0 (en) Polypeptides
GB0121215D0 (en) Polypeptide
GB2381387B (en) Limit switch
GB0113257D0 (en) Polypeptides
GB0027395D0 (en) Anti-angiogenic peptides
GB0019705D0 (en) Factor
GB0018908D0 (en) Polypeptides
GB0021685D0 (en) Polypeptides
GB0008945D0 (en) Polypeptides
AU2002230728A8 (en) Protein-protein interactions
AU141881S (en) Pallet angle
AU145426S (en) Pallet angle
CA89552S (en) Pallet
CA89553S (en) Pallet
CA89440S (en) Pallet
CA88521S (en) Pallet